Skip to main content

Table 2 Physician-reported current acute treatment patterns in insufficient responders/sufficient responders to acute treatment for migraine

From: Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme

 

Insufficient responders (N = 227)

Sufficient responders (N = 311)

Total (N = 538)

Number of prescribed acute regimens ever (% of total acute prescriptions)

 0

4 (1.8)

1 (0.3)

5 (0.9)

 1

147 (64.8)

211 (68.1)

358 (66.7)

 2

50 (22.0)

74 (23.9)

124 (23.1)

  ≥ 3

26 (11.5)

24 (7.7)

50 (9.3)

Prescribed acute medication type, n (%)a

 NSAIDs (including in combinations)

99 (43.6)

115 (37.0)

214 (39.8)

 Triptans

171 (75.3)

214 (68.8)

385 (71.6)

 Opioid analgesics (including in combinations)

0

0

0

Patient currently taking OTC medications, n (%)

12 (6.5)

22 (9.0)

34 (7.9)

Currently taking OTC and/or prescribed acute*

 Prescribed acute treatment only

171 (91.9)

220 (89.8)

391 (90.7)

 OTC and prescribed acute

11 (5.9)

22 (9.0)

33 (7.7)

 OTC only

1 (0.5)

0

1 (0.2)

 Taking neither

3 (1.6)

3 (1.2)

6 (1.4)

  1. Reported data are number and percentage of patients, with percentages calculated as proportion of non-missing data
  2. *p < 0.05 between insufficient responders and sufficient responders. Chi-squared or Fisher’s exact test was used
  3. aOccurring in ≥5% of patients
  4. NSAID nonsteroidal anti-inflammatory drug; OTC over the counter